Health-tracking bodysuits and bed covers plus 7 other crowdfunded health projects

By: Jonah Comstock | Jan 30, 2015        

Tags: | | | | | | | | | | | |  |

The past few weeks have been good to digital health projects on crowdfunding platforms Indiegogo and Kickstarter. While some of the nine projects below are the latest in a long line of takes on the wristworn activity tracker, others facilitate the tracking of temperature, blood glucose, sleep, or concussions. And most of these projects have already surpassed their funding goals. Read on to see what the latest digital health entrepreneurs who choose to turn to crowdfunding have up their sleeves.


Diabeto packaging

Diabeto is tackling the same use case Glooko started out pursuing: how to get data from a glucometer into a smartphone and make that data actionable for people with type 1 and type 2 diabetes. The Diabeto approach is a small, cutely designed piece of hardware that can plug into the glucometer, and then wirelessly transfer data into a smartphone. The company is also working on an app that will allow users to keep blood glucose logs, and also track insulin, carbohydrates, and mood. An open API will allow developers to create new apps that work with the device. Diabeto is already overfunded, with nearly $15,000 raised out of a $10,000 goal. Keep reading>>


Glow taps Walgreens’ Rx API for birth control refills

By: Aditi Pai | Jan 30, 2015        

Tags: | | | |  |

Glow WalgreensSan Francisco-based Glow, maker of digital health tools for women, integrated Walgreens’ Prescription Refill API into its app so that Glow users can refill their birth control prescriptions directly from their Android or iOS app.

This refill feature extends to Walgreens subsidiary Duane Reade as well.

Walgreens first made its medication refill API available to developers in February 2013. The company tells MobiHealthNews that a dozen other apps have made use of the API since: Capzule PHR, CloudMetRx, DailyRx, GenieMD, HealthSavvi, Healthspek, Mobile Health Library, OnTimeRx, PocketPharmacist, Rxmindme, WebMD Rx, and ZipScript.

Glow’s first app, also called Glow, was initially designed for women who want to get pregnant, but expanded soon after to include women who are not trying to conceive, but want to track their periods. Based on the option a woman selects in the app, she can track her fertility cycle, view trends, and receive notifications aimed at helping her live a healthier lifestyle or get pregnant.  Keep reading>>

Webinar today: Digital Health Trends in 2015

By: Brian Dolan | Jan 29, 2015        

Tags: | | |  |

Brian Dolan - MobiHealthNews Editor-in-ChiefThis afternoon MobiHealthNews will host its first webinar of the year, aptly focused on Digital Health Trends in 2015. We already have almost 1,700 people registered for today’s event, which starts very soon: at 2PM ET. But there is still time to sign up, and still room for more.

Bring your questions about the year ahead, join us for some predictions and our always jam-packed Q&A session. Sign up right here.

Study: App increases adherence to sun protection

By: Aditi Pai | Jan 29, 2015        

Tags: | | | | | |  |

CHCF Smartphones in Health Care ReportPeople who used an app designed to help protect themselves from the harmful effects of the sun saw an improvement in adherence to a sun safety regimen, according to two studies published in the Journal of the American Medical Association (JAMA) Dermatology this week.

The app, called Solar Cell, was created as part of a partnership between Klein Buendel, where lead researcher David B. Buller is a research partner, and the National Cancer Institute. Solar Cell offers advice on sun protection, alerts to apply sunscreen, reapply sunscreen, and get out of the sun, hourly UV Index, vitamin D production based on the forecast UV Index, and the phone’s time and location.

In the first study, conducted in 2012, researchers recruited 604 adults who owned smartphones — 305 were put into a treatment group, but just 125 ended up using the app. After 10 weeks, researchers measured the percentage of days participants used sun protection, time they spent outdoors in the midday sun, and number of sunburns in the past three months. Keep reading>>

Roche, Qualcomm partner to monitor patients on blood thinners

By: Jonah Comstock | Jan 29, 2015        

Tags: | | | | | | |  |

2netHubFrontLess than a month after announcing its partnership with Novartis, Qualcomm is adding another big pharmaceutical company to its list of 2net partners: Roche, who will use Qualcomm Life’s 2net platform to capture patient data from connected devices, starting with anti-coagulation meters.

“This collaboration marks a significant milestone for Roche as we launch a new generation of point-of-care solutions that enable healthcare professionals to better keep in touch remotely with patients, whenever and wherever they are,” Jeremy Moss, senior vice president of Point of Care at Roche Professional Diagnostics said in a statement. “By combining Qualcomm Life’s leadership in powering connected health solutions with our point-of-care expertise, we are taking an important step forward to realize our connected care strategy; ultimately enabling physicians to improve the overall quality of life for patients.”

In addition to its pharmaceutical business, Roche’s Point of Care product suite includes back-end testing systems for anticoagulants, blood glucose, blood gas and electrolytes, and urinalysis. The partnership will initially focus on anti-coagulation meters but could expand into these other areas as well.  Keep reading>>

Toumaz made $1M from peel-and-stick vitals sensor last year

By: Jonah Comstock | Jan 29, 2015        

Tags: | | | | | |  |

SensiumvitalsToumaz, a developer of low-power wireless systems, made $1.1 million (750,000 pounds) off the first deployments of its SensiumVitals healthcare monitoring technology according to the company’s annual trading update. That’s up from just $90,000 (60,000 pounds) last year.

SensiumVitals is a peel-and-stick sensor that continuously monitors vital signs, including temperature, heart rate, and respiration rate and transmits that data wirelessly to a hospital monitor. Toumaz is one of the early players in digital health: it was already testing its sensor in 2009. In 2011, it received a $2 million investment from NantHealth, which a few months later became the technology’s US distributor.

Toumaz’s healthcare business is a small portion of its revenue though, with the majority coming from its digital audio business. The total revenue for the company last year was just shy of $40 million (26.2 million pounds).

“In healthcare, the first deployments of SensiumVitals provided us with early revenues and valuable experience,” CEO Anthony Sethill said in a statement. “Our deployments are expected to gain increasing traction across a number of territories over the next few months.”

The technology is currently deployed in the UK, the US, Australia, and Portugal, including Spire Healthcare’s Montefiore Hospital in the UK, and Hurley Medical Center in Flint, Michigan. The technology was also piloted at St. John’s Health Center in Santa Monica, California. It is used in a mix of general ward and emergency room settings.

Toumaz said in the update that the company has continued to iterate the software based on feedback from customers, and has begun a second round of deployments in Italy and France. The company is also working with the University of Leicester to add blood pressure and blood oxygenation (Sp02) to future generations of the device.

On its website, the company gives some indications of its future plans as well, which could take SensiumVitals out of the hospital and into the home.

“Looking longer term, the group has been assessing potential opportunities in the home health sector,” they write. “Opportunities may exist to introduce tailored SensiumVitals solutions for patients recently discharged from hospital or those with long term chronic conditions such as congestive heart failure (CHF), chronic obstructive pulmonary disease (COPD) or diabetes. However, in the short term, the company’s key priority is to build the SensiumVitals business in the hospital market.”